MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 129 filers reported holding MERSANA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 4.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $149,062 | -85.0% | 117,372 | -61.1% | 0.00% | – |
| Q2 2023 | $991,912 | -76.2% | 301,493 | -70.3% | 0.00% | – |
| Q1 2023 | $4,175,282 | -6.3% | 1,015,884 | +33.5% | 0.00% | -100.0% |
| Q4 2022 | $4,457,837 | +65.8% | 760,723 | +91.3% | 0.00% | – |
| Q3 2022 | $2,688,000 | +926.0% | 397,646 | +600.4% | 0.00% | – |
| Q2 2022 | $262,000 | +89.9% | 56,777 | +64.5% | 0.00% | – |
| Q1 2022 | $138,000 | -48.1% | 34,505 | -19.5% | 0.00% | – |
| Q4 2021 | $266,000 | -63.6% | 42,847 | -44.6% | 0.00% | – |
| Q3 2021 | $730,000 | -2.7% | 77,385 | +40.1% | 0.00% | – |
| Q2 2021 | $750,000 | +38.9% | 55,232 | +65.4% | 0.00% | – |
| Q1 2021 | $540,000 | -94.6% | 33,391 | -91.1% | 0.00% | -100.0% |
| Q4 2020 | $10,039,000 | -9.9% | 377,279 | -37.0% | 0.00% | -50.0% |
| Q3 2020 | $11,142,000 | +6.7% | 598,404 | +34.2% | 0.00% | 0.0% |
| Q2 2020 | $10,438,000 | +493.4% | 446,059 | +47.8% | 0.00% | – |
| Q1 2020 | $1,759,000 | +674.9% | 301,760 | +662.3% | 0.00% | – |
| Q4 2019 | $227,000 | +254.7% | 39,583 | -2.6% | 0.00% | – |
| Q3 2019 | $64,000 | -66.1% | 40,633 | -12.9% | 0.00% | – |
| Q2 2019 | $189,000 | +3.3% | 46,666 | +34.4% | 0.00% | – |
| Q1 2019 | $183,000 | +41.9% | 34,713 | +9.1% | 0.00% | – |
| Q4 2018 | $129,000 | +514.3% | 31,807 | +1409.6% | 0.00% | – |
| Q3 2018 | $21,000 | -38.2% | 2,107 | +8.8% | 0.00% | – |
| Q2 2018 | $34,000 | -52.8% | 1,937 | -57.1% | 0.00% | – |
| Q1 2018 | $72,000 | -52.0% | 4,513 | -50.4% | 0.00% | – |
| Q4 2017 | $150,000 | +64.8% | 9,100 | +73.5% | 0.00% | – |
| Q3 2017 | $91,000 | – | 5,244 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 4,005,600 | $64,810,000 | 6.21% |
| Bain Capital Life Sciences Investors, LLC | 3,695,667 | $59,796,000 | 3.39% |
| COMMODORE CAPITAL LP | 429,228 | $6,945,000 | 2.77% |
| ACUTA CAPITAL PARTNERS, LLC | 357,689 | $5,787,000 | 2.09% |
| Avoro Capital Advisors LLC | 6,800,000 | $110,024,000 | 1.90% |
| Ghost Tree Capital, LLC | 450,000 | $7,281,000 | 1.71% |
| RHO CAPITAL PARTNERS INC | 796,458 | $12,887,000 | 1.24% |
| Rock Springs Capital Management LP | 2,775,127 | $44,902,000 | 0.98% |
| Sio Capital Management, LLC | 157,259 | $2,544,000 | 0.52% |
| Bellevue Group AG | 2,850,010 | $46,113,000 | 0.49% |